Hancock Jaffe Laboratories Inc (HJLI)

Overview

Hancock Jaffe Laboratories, Inc. is a pioneering medical device company committed to developing innovative tissue-based solutions aimed at providing essential support to individuals with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). With a strategic focus on biologic-based products, the company endeavors to enhance the quality of life for patients enduring these debilitating conditions. Operating from its headquarters in Irvine, California, Hancock Jaffe Laboratories maintains a dedicated workforce of 9 full-time employees, underscoring its commitment to advancing medical technology and improving patient outcomes through its development-stage initiatives.

Products and Services

The following are key products currently being developed by Hancock Jaffe Laboratories:

• Bioprosthetic Heart Valve (BHV): This pioneering bioprosthetic device, crafted from pig heart valves, is engineered to emulate the function of a native heart valve. Designed for patients with cardiovascular disease, the BHV aims to offer superior functional performance compared to existing devices. Its development represents a significant advancement in the treatment of heart valve conditions, providing a potentially life-enhancing solution for those in need.
• Venous Valve: Specifically tailored for patients suffering from lower limb chronic venous insufficiency (CVI), a condition often resulting from valve damage due to deep vein thrombosis, the Venous Valve is another bioprosthetic device derived from pig venous valves. Its purpose is to restore proper venous circulation in the legs, thereby alleviating symptoms and improving the quality of life for individuals affected by CVI. This innovative product highlights Hancock Jaffe Laboratories’ commitment to addressing a wide spectrum of cardiovascular and venous diseases through its biologic-based solutions.